Established and potential therapeutic applications of octreotide in palliative care

Eric E. Prommer

Research output: Contribution to journalReview articlepeer-review

26 Scopus citations


Octreotide acetate was developed as a pharmacologically stable, long-acting analogue of the hormone somatostatin. Mimicking the actions of somatostatin, octreotide has been used for its antisecretory effects. Randomized control trials have established the efficacy of octreotide for malignant bowel obstruction and for chemotherapy-induced diarrhea. Octreotide has proven to be an effective agent for symptoms of carcinoid syndrome. Newer uses include for bone marrow transplantation, infectious diarrheal syndromes, and management of hepatic metastases. More evidence is needed for the establishment of its efficacy for hypercalcemia, pain, pleural effusions, diarrhea after celiac plexus block, and malignant ascites.

Original languageEnglish (US)
Pages (from-to)1117-1123
Number of pages7
JournalSupportive Care in Cancer
Issue number10
StatePublished - Oct 2008


  • Bowel obstruction
  • Diarrhea
  • Somatostatin

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Established and potential therapeutic applications of octreotide in palliative care'. Together they form a unique fingerprint.

Cite this